Cancer genome sequencing projects focus exclusively on the discovery of somatic changes. A new study shows that germline alterations in the proapoptotic protein BIM can have a crucial role in how a tumor responds to treatment (pages 521–528).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
Oncogenesis Open Access 25 March 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Glickman, M.S. & Sawyers, C.L. Cell 148, 1089–1098 (2012).
Ng, K.P. et al. Nat. Med. 18, 521–528 (2012).
Youle, R.J. & Strasser, A. Nat. Rev. Mol. Cell Biol. 9, 47–59 (2008).
Letai, A. et al. Cancer Cell 2, 183–192 (2002).
Kim, H. et al. Nat. Cell Biol. 8, 1348–1358 (2006).
Ren, D. et al. Science 330, 1390–1393 (2010).
Kuribara, R. et al. Mol. Cell. Biol. 24, 6172–6183 (2004).
Gong, Y. et al. PLoS Med. 4, e294 (2007).
Costa, D.B. et al. PLoS Med. 4, 1669–1679 (2007).
Cragg, M.S., Kuroda, J., Puthalakath, H., Huang, D.C. & Strasser, A. PLoS Med. 4, 1681–1689 (2007).
Au, W.Y. et al. Int. J. Hematol. 89, 14–23 (2009).
Egle, A., Harris, A.W., Bouillet, P. & Cory, S. Proc. Natl. Acad. Sci. USA 101, 6164–6169 (2004).
Erlacher, M. et al. J. Exp. Med. 203, 2939–2951 (2006).
Fesik, S.W. Nat. Rev. Cancer 5, 876–885 (2005).
LaCasse, E.C. et al. Oncogene 27, 6252–6275 (2008).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Cheng, E., Sawyers, C. In cancer drug resistance, germline matters too. Nat Med 18, 494–496 (2012). https://doi.org/10.1038/nm.2725
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2725
This article is cited by
-
Epidermal growth factor receptor mutations in lung adenocarcinoma
Laboratory Investigation (2014)
-
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
Oncogenesis (2013)